1
|
Gómez-Bouzó U, Peluso-Iltis C, Santalla H, Quevedo MA, Verlinden L, Verstuyf A, Fall Y, Gómez G, Rochel N. Design, Synthesis, and Biological Evaluation of New Type of Gemini Analogues with a Cyclopropane Moiety in Their Side Chain. J Med Chem 2024; 67:10386-10400. [PMID: 38858308 DOI: 10.1021/acs.jmedchem.4c00854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2024]
Abstract
We synthesized two new gemini analogues, UG-480 and UG-481, that incorporate a modified longer side chain containing a cyclopropane group. The evaluation of the bioactivities of the two gemini analogues indicated that the 17,20 threo (20S) compound, UG-480, is the most active one and is as active as 1,25(OH)2D3. Docking and molecular dynamics (MD) data showed that the compounds bind efficiently to vitamin D receptor (VDR) with UG-480 to form an energetically more favorable interaction with His397. Structural analysis indicated that whereas the UG-480 compound efficiently stabilizes the active VDR conformation, it induces conformational changes in the H6-H7 VDR region that are greater than those induced by the parental Gemini and that this is due to the occupancy of the secondary channel by its modified side chain.
Collapse
Affiliation(s)
- Uxía Gómez-Bouzó
- Departamento de Química Orgánica and Instituto de Investigación Sanitaría Galicia Sur (IISGS), Campus Lagoas Marcosende, Universidad de Vigo, Vigo 36310, Spain
| | - Carole Peluso-Iltis
- Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch 67400, France
- CNRS UMR 7104, Illkirch 67400, France
- Inserm U1258, Illkirch 67400, France
- University of Strasbourg, Illkirch 67400, France
| | - Hugo Santalla
- Departamento de Química Orgánica and Instituto de Investigación Sanitaría Galicia Sur (IISGS), Campus Lagoas Marcosende, Universidad de Vigo, Vigo 36310, Spain
| | - Mario Alfredo Quevedo
- Unidad de Investigación y desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET and Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba X5000HUA, Argentina
| | - Lieve Verlinden
- Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven 3000, Belgium
| | - Annemieke Verstuyf
- Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven 3000, Belgium
| | - Yagamare Fall
- Departamento de Química Orgánica and Instituto de Investigación Sanitaría Galicia Sur (IISGS), Campus Lagoas Marcosende, Universidad de Vigo, Vigo 36310, Spain
| | - Generosa Gómez
- Departamento de Química Orgánica and Instituto de Investigación Sanitaría Galicia Sur (IISGS), Campus Lagoas Marcosende, Universidad de Vigo, Vigo 36310, Spain
| | - Natacha Rochel
- Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch 67400, France
- CNRS UMR 7104, Illkirch 67400, France
- Inserm U1258, Illkirch 67400, France
- University of Strasbourg, Illkirch 67400, France
| |
Collapse
|
2
|
Belorusova AY, Rovito D, Chebaro Y, Doms S, Verlinden L, Verstuyf A, Metzger D, Rochel N, Laverny G. Vitamin D Analogs Bearing C-20 Modifications Stabilize the Agonistic Conformation of Non-Responsive Vitamin D Receptor Variants. Int J Mol Sci 2022; 23:ijms23158445. [PMID: 35955580 PMCID: PMC9369186 DOI: 10.3390/ijms23158445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 07/26/2022] [Accepted: 07/27/2022] [Indexed: 12/04/2022] Open
Abstract
The Vitamin D receptor (VDR) plays a key role in calcium homeostasis, as well as in cell proliferation and differentiation. Among the large number of VDR ligands that have been developed, we have previously shown that BXL-62 and Gemini-72, two C-20-modified vitamin D analogs are highly potent VDR agonists. In this study, we show that both VDR ligands restore the transcriptional activities of VDR variants unresponsive to the natural ligand and identified in patients with rickets. The elucidated mechanisms of action underlying the activities of these C-20-modified analogs emphasize the mutual adaptation of the ligand and the VDR ligand-binding pocket.
Collapse
Affiliation(s)
- Anna Y. Belorusova
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), F-67400 Illkirch, France; (A.Y.B.); (D.R.); (Y.C.); (D.M.)
- Centre National de la Recherche Scientifique (CNRS), UMR 7104, F-67400 Illkirch, France
- Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1258, F-67400 Illkirch, France
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, INSERM U1258, CNRS UMR 7104, 67404 Illkirch, France
| | - Daniela Rovito
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), F-67400 Illkirch, France; (A.Y.B.); (D.R.); (Y.C.); (D.M.)
- Centre National de la Recherche Scientifique (CNRS), UMR 7104, F-67400 Illkirch, France
- Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1258, F-67400 Illkirch, France
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, INSERM U1258, CNRS UMR 7104, 67404 Illkirch, France
- OSCAR, French Network for Rare Bone Diseases, 94270 Le Kremlin-Bicêtre, France
| | - Yassmine Chebaro
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), F-67400 Illkirch, France; (A.Y.B.); (D.R.); (Y.C.); (D.M.)
- Centre National de la Recherche Scientifique (CNRS), UMR 7104, F-67400 Illkirch, France
- Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1258, F-67400 Illkirch, France
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, INSERM U1258, CNRS UMR 7104, 67404 Illkirch, France
| | - Stefanie Doms
- Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium; (S.D.); (L.V.); (A.V.)
| | - Lieve Verlinden
- Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium; (S.D.); (L.V.); (A.V.)
| | - Annemieke Verstuyf
- Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium; (S.D.); (L.V.); (A.V.)
| | - Daniel Metzger
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), F-67400 Illkirch, France; (A.Y.B.); (D.R.); (Y.C.); (D.M.)
- Centre National de la Recherche Scientifique (CNRS), UMR 7104, F-67400 Illkirch, France
- Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1258, F-67400 Illkirch, France
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, INSERM U1258, CNRS UMR 7104, 67404 Illkirch, France
- OSCAR, French Network for Rare Bone Diseases, 94270 Le Kremlin-Bicêtre, France
| | - Natacha Rochel
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), F-67400 Illkirch, France; (A.Y.B.); (D.R.); (Y.C.); (D.M.)
- Centre National de la Recherche Scientifique (CNRS), UMR 7104, F-67400 Illkirch, France
- Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1258, F-67400 Illkirch, France
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, INSERM U1258, CNRS UMR 7104, 67404 Illkirch, France
- Correspondence: (N.R.); (G.L.)
| | - Gilles Laverny
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), F-67400 Illkirch, France; (A.Y.B.); (D.R.); (Y.C.); (D.M.)
- Centre National de la Recherche Scientifique (CNRS), UMR 7104, F-67400 Illkirch, France
- Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1258, F-67400 Illkirch, France
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, INSERM U1258, CNRS UMR 7104, 67404 Illkirch, France
- OSCAR, French Network for Rare Bone Diseases, 94270 Le Kremlin-Bicêtre, France
- Correspondence: (N.R.); (G.L.)
| |
Collapse
|
3
|
Gómez-Bouzó U, Fall A, Osz J, Fall Y, Rochel N, Santalla H. Development of novel Gemini-cholesterol analogues for Retinoid-related Orphan Receptor. Org Chem Front 2022. [DOI: 10.1039/d2qo00040g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Retinoic-acid-related Orphan Receptors (RORs) regulate maintenance of the circadian rhythm and immune response among others and are involved in increasing number of pathologies including autoimmune diseases, cancer and neurological disorders...
Collapse
|
4
|
Shan NL, Minden A, Furmanski P, Bak MJ, Cai L, Wernyj R, Sargsyan D, Cheng D, Wu R, Kuo HCD, Li SN, Fang M, Maehr H, Kong AN, Suh N. Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma In Situ by Vitamin D Compounds. Cancer Prev Res (Phila) 2020; 13:673-686. [PMID: 32467291 DOI: 10.1158/1940-6207.capr-19-0566] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2019] [Revised: 04/01/2020] [Accepted: 05/20/2020] [Indexed: 12/21/2022]
Abstract
Ductal carcinoma in situ (DCIS), which accounts for one out of every five new breast cancer diagnoses, will progress to potentially lethal invasive ductal carcinoma (IDC) in about 50% of cases. Vitamin D compounds have been shown to inhibit progression to IDC in the MCF10DCIS model. This inhibition appears to involve a reduction in the cancer stem cell-like population in MCF10DCIS tumors. To identify genes that are involved in the vitamin D effects, a global transcriptomic analysis was undertaken of MCF10DCIS cells grown in mammosphere cultures, in which cancer stem-like cells grow preferentially and produce colonies by self-renewal and maturation, in the presence and absence of 1α25(OH)2D3 and a vitamin D analog, BXL0124. Using next-generation RNA-sequencing, we found that vitamin D compounds downregulated genes involved in maintenance of breast cancer stem-like cells (e.g., GDF15), epithelial-mesenchymal transition, invasion, and metastasis (e.g., LCN2 and S100A4), and chemoresistance (e.g., NGFR, PPP1R1B, and AGR2), while upregulating genes associated with a basal-like phenotype (e.g., KRT6A and KRT5) and negative regulators of breast tumorigenesis (e.g., EMP1). Gene methylation status was analyzed to determine whether the changes in expression induced by vitamin D compounds occurred via this mechanism. Ingenuity pathway analysis was performed to identify upstream regulators and downstream signaling pathway genes differentially regulated by vitamin D, including TP63 and vitamin D receptor -mediated canonical pathways in particular. This study provides a global profiling of changes in the gene signature of DCIS regulated by vitamin D compounds and possible targets for chemoprevention of DCIS progression to IDC in patients.
Collapse
Affiliation(s)
- Naing Lin Shan
- Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Audrey Minden
- Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.,Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
| | - Philip Furmanski
- Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.,Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
| | - Min Ji Bak
- Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Li Cai
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.,Department of Biomedical Engineering, School of Engineering, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Roman Wernyj
- Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Davit Sargsyan
- Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - David Cheng
- Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Renyi Wu
- Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Hsiao-Chen D Kuo
- Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Shanyi N Li
- Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Mingzhu Fang
- Environmental and Occupational Health Sciences Institute and School of Public Health, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Hubert Maehr
- Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Ah-Ng Kong
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.,Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey
| | - Nanjoo Suh
- Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey. .,Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
| |
Collapse
|
5
|
Abstract
![]()
For many individuals,
in particular during winter, supplementation
with the secosteroid vitamin D3 is essential for the prevention
of bone disorders, muscle weakness, autoimmune diseases, and possibly
also different types of cancer. Vitamin D3 acts via its
metabolite 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3]
as potent agonist of the transcription factor vitamin D receptor (VDR).
Thus, vitamin D directly affects chromatin structure and gene regulation
at thousands of genomic loci, i.e., the epigenome and transcriptome
of its target tissues. Modifications of 1,25(OH)2D3 at its
side-chain, A-ring, triene system, or C-ring, alone and in combination,
as well as nonsteroidal mimics provided numerous potent VDR agonists
and some antagonists. The nearly 150 crystal structures of VDR’s
ligand-binding domain with various vitamin D compounds allow a detailed
molecular understanding of their action. This review discusses the
most important vitamin D analogs presented during the past 10 years
and molecular insight derived from new structural information on the
VDR protein.
Collapse
Affiliation(s)
- Miguel A Maestro
- Departamento de Química-CICA , Universidade da Coruña , ES-15071 A Coruña , Spain
| | - Ferdinand Molnár
- School of Science and Technology, Department of Biology , Nazarbayev University , KZ-010000 Astana , Kazakhstan
| | - Carsten Carlberg
- School of Medicine, Institute of Biomedicine , University of Eastern Finland , FI-70211 Kuopio , Finland
| |
Collapse
|